-
Madison Square Garden Entertainment (MSGE) PT Raised to $60 at Goldman Sachs
-
Wolfe Research Downgrades Madison Square Garden Entertainment (MSGE) to Peerperform
-
Madison Square Garden Entertainment (MSGE) Tops Q1 EPS by 21c
-
Here are the October additions to Goldman's 'U.S. Conviction List - Directors' Cut
-
Goldman Updates US Monthly Directors' Cut Conviction List, Fours Adds and Three Removals
-
BofA Changes Endeavor List Members
-
MSG Entertainment buys back $25 million in shares over three weeks
-
BofA Securities Reiterates Buy Rating on Madison Square Garden Entertainment (MSGE)
-
Madison Square Garden Entertainment (MSGE) PT Lowered to $42 at Goldman Sachs
-
Madison Square Garden Entertainment (MSGE) Misses Q4 EPS by 18c
-
Madison Square Garden Entertainment (MSGE) Misses Q3 EPS by 26c
-
Madison Square Garden Entertainment (MSGE) Appoints David Collins as CFO
-
Madison Square Garden Entertainment (MSGE) October 30 and 35 calls active
-
Wolfe Research Upgrades Madison Square Garden Entertainment (MSGE) to Outperform
-
Madison Square Garden Entertainment (MSGE) PT Raised to $250 at Macquarie
-
Agios Pharma (AGIO) BofA Makes Changes to Endeavor List
-
Madison Square Garden Entertainment (MSGE) Misses Q2 EPS by 35c
-
Guggenheim Names Madison Square Garden Entertainment (MSGE) as Best Idea
-
Madison Square Garden Entertainment (MSGE) Tops Q1 EPS by 9c
-
Madison Square Garden Entertainment (MSGE) PT Raised to $49 at Guggenheim
-
Madison Square Garden Entertainment (MSGE) PT Raised to $43 at JPMorgan
-
Goldman Sachs Reiterates Buy Rating on Madison Square Garden Entertainment (MSGE)
-
Madison Square Garden Entertainment (MSGE) Tops Q4 EPS by 192c
-
Madison Square Garden Entertainment (MSGE) option implied volatility elevated into quarter results
-
Goldman Sachs Upgrades Madison Square Garden Entertainment (MSGE) to Buy

